• search navRechercher
  • français
  • Connexion

Qualifications

 

Irving, Texas qualification criteria

General qualifications for enrolling in studies at our Irving site (Individual studies will have further qualifications)


Potential study participants must be in good general health, be able to read and understand English, and have a valid U.S. government-issued photo ID. Study participants cannot be taking medication for asthma, diabetes or have any autoimmune disorder, and cannot be pregnant, nursing, or planning a pregnancy.

Available studies in Irving

Acne-Prone Skin Patch Study

18 Males & Females Ages 18-50
Patch Study
13 visits over 4 weeks (MWF Visits only)
Study pays upon completion: $300

Requirements: Acne-prone skin

    Must have acne-prone skin on the back to qualify
    Does not require previous history of doing patch studies/new patch participants okay

Study Start Dates: 5/7 (2025)

5/7/25

Submit an application

Oral Chew Product

THIS STUDY AVAILABLE TO TAKE CALLS STARTING MONDAY, MAY 5, 2025

This is a research study related to alleviating the side effects of GLP-1 medications by using over the counter (OTC) oral chew products. These products are currently marketed and can be purchased without a prescription in stores where you normally shop. The sponsor (Prestige Consumer Healthcare, Inc.) wants to learn more about them.

Glucagon-like peptide-1 (GLP-1) are a class of drugs used to treat obesity and type 2 diabetes. They work by mimicking the actions of the GLP-1 hormone, which is released by the gut after eating.
GLP-1 help control blood sugar and insulin levels and promote feelings of fullness.

Study Details
2 Visits in office
Up to $200.00 for all complete visits

Requirements: Males and Females, See Qualifications

    • Males and Females
    • Age 18 and older
    • Have or just received a prescription for a non-compounded GLP-1 (examples: exenatide, liraglutide, dulaglutide, and semaglutide); or

       

    • Are just about to do a step-change for a non-compounded GLP-1 (examples: exenatide, liraglutide, dulaglutide, and semaglutide)
      • Step-change only: you have experienced Nausea related to taking one of the non-compound GLP-1 medications listed above

Study Start Dates: 05/05 (2025)

Multiple start dates beginning 5/5/25

Submit an application

Asians Needed!

Asian ethnicities needed for upcoming studies! Please watch for upcoming study posts. Existing panelists, send in your referrals and see study details for more!

Requirements: Asian males and females

    Asian males and females

Study Start Dates: Spring (2025)

Watch for future study posts!

Submit an application

×
Please indicate your current status:

FIRST-TIME
panelist

For repeat panelist, please call to apply: (972) 871-7578, select option "1"

Recruiters are available to speak with you Monday-Friday, 9 a.m. to 6 p.m. CT. If you call before or after normal business hours, please leave your name, call-back number, and the best time to return your call. A recruiter will return your call as soon as possible.

 
v.1.1.1224